Cargando…

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer

Brain metastasis is a common and serious complication of breast cancer, which is commonly associated with poor survival and prognosis. In particular, the treatment of brain metastasis from triple-negative breast cancer (BM-TNBC) has to face the distinct therapeutic challenges from tumor heterogeneit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Zimiao, Wu, Sunyi, Zhou, Jianfen, Xu, Weixia, Xu, Qianzhu, Lu, Linwei, Xie, Cao, Liu, Yu, Lu, Weiyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939358/ https://www.ncbi.nlm.nih.gov/pubmed/36815053 http://dx.doi.org/10.1016/j.apsb.2022.03.026

Ejemplares similares

Drug Nanocrystals for Active Tumor-Targeted Drug Delivery
por: Lu, Linwei, et al.
Publicado: (2022)

All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide
por: Ran, Danni, et al.
Publicado: (2020)

Engineered platelets-based drug delivery platform for targeted thrombolysis
por: Wang, Songli, et al.
Publicado: (2022)

A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated
por: Li, Jinyang, et al.
Publicado: (2021)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
por: Wan, Xu, et al.
Publicado: (2016)

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
por: Zhang, Ying, et al.
Publicado: (2022)

Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis
por: Chen, Cai-Ping, et al.
Publicado: (2022)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
por: Ma, Yanfei, et al.
Publicado: (2022)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer
por: Pan, Jhih-Kai, et al.
Publicado: (2021)

TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer
por: Tao, Tao, et al.
Publicado: (2016)

Risk factors for distant metastasis of patients with primary triple-negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019)

Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
por: Lin, Cheng-Han, et al.
Publicado: (2022)

Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
por: Lee, Kha-Liang, et al.
Publicado: (2020)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
por: Lv, Yan, et al.
Publicado: (2021)

Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer
por: Ji, Kyungmin, et al.
Publicado: (2021)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis
por: Yang, Wen-Jing, et al.
Publicado: (2020)

Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice
por: Luo, Xu-Liang, et al.
Publicado: (2020)

ASMT Regulates Tumor Metastasis Through the Circadian Clock System in Triple-Negative Breast Cancer
por: Xie, FenFen, et al.
Publicado: (2020)

SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
por: Zhang, Z, et al.
Publicado: (2017)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis
por: Shubhra, Quazi T. H.
Publicado: (2023)

RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis
por: Yin, Zhuming, et al.
Publicado: (2021)

Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2020)

Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer
por: Luo, Hanjia, et al.
Publicado: (2023)

Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma
por: Geredeli, Caglayan, et al.
Publicado: (2015)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Liu, Daxing, et al.
Publicado: (2018)

GPR110 promotes progression and metastasis of triple-negative breast cancer
por: Nam, Hye-Jung, et al.
Publicado: (2022)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Advances in the Management of Early-Stage Triple-Negative Breast Cancer
por: Bhardwaj, Prarthna V., et al.
Publicado: (2023)

A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple‐negative breast cancer
por: Lin, Mingxi, et al.
Publicado: (2020)

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
por: Pan, Mei-Ren, et al.
Publicado: (2019)

Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
por: Zhou, Li, et al.
Publicado: (2017)

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
por: Li, Yi-Qun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tufgck70f3teprvbsh50dubh1c